Laura Bush

Biotech, and bioprocessing more specifically, is a great place to be. But it's time for a new adventure.

China's regulators acknowledge the quality gap, and have a plan for steady improvement.

Good leaders look beyond industry woes to focus on patients

Industry and regulators disagree over noncritical parameters.